A Long-Term Survival Case of Primary Angiosarcoma in Liver Treated with Weekly Docetaxel Chemotherapy
- Affiliated Author(s)
- 김진영; 도영록; 박건욱; 송홍석
- Alternative Author(s)
- Kim, Jin Young; Do, Young Rok; Park, Keon Uk; Song, Hong Suk
- Journal Title
- Keimyung Medical Journal
- Issued Date
- Angiosarcoma; Docetaxel; Liver
- Angiosarcoma is rare malignant endothelial cell tumor of vascular or lymphatic origin. It may occur in any region of the body, but more frequent in skin and soft tissue. Though hepatic angiosarcoma is rare primary tumor of the liver, it is the third most common primary malignant tumor of the liver. Treatment options for hepatic angiosarcoma are limited, and they depend mainly on the stage of the disease during diagnosis. We report a rare case of primary angiosarcoma of the liver. We treated our patient with weekly docetaxel chemotherapy regimen.
She received a total of six cycles without disease progression or unendurable toxicity occurred, and had long-term survival fourteen months after the diagnosis. An effective treatment for hepatic angiosarcoma has not yet been established. Chemotherapy with docetaxel should be considered in the treatment of patients with primary angiosarcoma of the liver.
- Authorize & License
- Files in This Item:
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.